Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial receptivity under different luteal phase support strategies after GnRH agonist trigger
2011-003250-34Phase 4Active
- Sponsor
- International Vaccine Institute
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of progesterone, lutropin alfa and human chorionic gonadotropin in ovarian hyperstimulation syndrome (OHSS) (5 arms), sponsored by International Vaccine Institute. Primary endpoint: Endometrial receptivity. Started Aug 2011; status: active.
02
Drugs
progesteronelutropin alfahuman chorionic gonadotropin
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on 2011-003250-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003250-34.